C1823 HCPCS Level II code: Generator, neurostimulator (implantable), non-rechargeable, with transvenous sensing and stimulation leads
C1823 is the HCPCS code for “Generator, neurostimulator (implantable), non-rechargeable, with transvenous sensing and stimulation leads” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
C1823Generator, neurostimulator (implantable), non-rechargeable, with transvenous sensing and stimulation leads
Short description: Gen, neuro, trans sen/stim
HCPCS · United States
Medicare details
The indicators CMS publishes with C1823 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Statute
- Type of service
- Other medical items or services; Ambulatory surgical center (facility usage for surgical services)
- BETOS category
- Medical/surgical supplies
- Coverage statute
- 1833(t)
- Added
- Jan 1, 2019
Where C1823 sits
- 1C codesOutpatient prospective payment system
- 2Active code C1823Generator, neurostimulator (implantable), non-rechargeable, with transvenous sensing and stimulation leads
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code C1823 mean?
C1823 is the HCPCS code for “Generator, neurostimulator (implantable), non-rechargeable, with transvenous sensing and stimulation leads” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover C1823?
CMS lists C1823’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Statute”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside C1823
All C codesC1817Septal defect implant system, intracardiacC1818Integrated keratoprosthesisC1819Surgical tissue localization and excision device (implantable)C1820Generator, neurostimulator (implantable), with rechargeable battery and charging systemC1821Interspinous process distraction device (implantable)C1822Generator, neurostimulator (implantable), high frequency, with rechargeable battery and charging systemC1824Generator, cardiac contractility modulation (implantable)C1825Generator, neurostimulator (implantable), non-rechargeable with carotid sinus baroreceptor stimulation lead(s)C1826Generator, neurostimulator (implantable), includes closed feedback loop leads and all implantable components, with rechargeable battery and charging systemC1827Generator, neurostimulator (implantable), non-rechargeable, with implantable stimulation lead and external paired stimulation controllerC1830Powered bone marrow biopsy needleC1831Interbody cage, anterior, lateral or posterior, personalized (implantable)